Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Amato

Showing results (201-210 of 237) with videos related to

Pageof 24
Sort By:
International Journal of Cancer|July 29, 2008
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligandsWei He, Sumith A Kularatne, Kimberly R Kalli, et al.
Urology|April 30, 2013
Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancerRobert J Amato, Vladislava Melnikova, Yujian Zhang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2009
Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) alone or administered in combination with interferon-alpha (IFN-alpha): a phase 2 trialRobert J Amato, William Shingler, Madusha Goonewardena, et al.
American Journal of Hematology|April 23, 2016
Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imigluceraseGregory M Pastores, Suma P Shankar, Milan Petakov, et al.
Prostate Cancer and Prostatic Diseases|February 23, 2005
The emerging role of the PI3-K-Akt pathway in prostate cancer progressionL Li, M M Ittmann, G Ayala, et al.
HIV Medicine|March 1, 2018
The HepHIV 2017 Conference in Malta: joining forces for the earlier diagnosis of HIV and viral hepatitisD Raben, M Hoekstra, I Sperle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trialC J Logothetis, L D Finn, T Smith, et al.
Sexually Transmitted Diseases|January 13, 2015
Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in EuropeMichelle J Cole, Gianfranco Spiteri, Katy Town, et al.
Investigational New Drugs|February 1, 1990
Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomasR H Earhart, D J Amato, A Y Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I study of suramin combined with doxorubicin in the treatment of androgen-independent prostate cancerS M Tu, L C Pagliaro, M E Banks, et al.
Pageof 24

Showing results (201-210 of 237) with videos related to

Sort By:
Pageof 24
International Journal of Cancer|July 29, 2008
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligandsWei He, Sumith A Kularatne, Kimberly R Kalli, et al.
Urology|April 30, 2013
Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancerRobert J Amato, Vladislava Melnikova, Yujian Zhang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2009
Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) alone or administered in combination with interferon-alpha (IFN-alpha): a phase 2 trialRobert J Amato, William Shingler, Madusha Goonewardena, et al.
American Journal of Hematology|April 23, 2016
Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imigluceraseGregory M Pastores, Suma P Shankar, Milan Petakov, et al.
Prostate Cancer and Prostatic Diseases|February 23, 2005
The emerging role of the PI3-K-Akt pathway in prostate cancer progressionL Li, M M Ittmann, G Ayala, et al.
HIV Medicine|March 1, 2018
The HepHIV 2017 Conference in Malta: joining forces for the earlier diagnosis of HIV and viral hepatitisD Raben, M Hoekstra, I Sperle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trialC J Logothetis, L D Finn, T Smith, et al.
Sexually Transmitted Diseases|January 13, 2015
Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in EuropeMichelle J Cole, Gianfranco Spiteri, Katy Town, et al.
Investigational New Drugs|February 1, 1990
Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomasR H Earhart, D J Amato, A Y Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I study of suramin combined with doxorubicin in the treatment of androgen-independent prostate cancerS M Tu, L C Pagliaro, M E Banks, et al.
Pageof 24